SLICE OF OLD-BOY STYLE HITS CITY FINE WINING AND DINING CIRCUIT July 8, 2009 NOT so long ago, City types were busy bemoaning the lack of decent restaurants on their patch. But now, just weeks after the Galvin brothers announced they were opening a new pad near Spitalfields market, I hear there’s a new eatery coming to town, courtesy of Simon Parker Bowles, former brother-in-law to Camilla, Duchess of [...]
Howard’s way wasn’t good enough for Sir Alan May 27, 2009 PICTURE the scene: Sir Alan, curtains drawn, feet up, one hand in a family pack of Monster Munch, the other flicking between home shopping channels, looking for a pair of diamonique earrings for his good lady wife. Yes, this week, he got his teams time on some sub-QVC teleshopping channel, shifting tomorrow’s charity shop donations [...]
How to keep yourself young and healthy while soaking up the rays May 18, 2009 IT’S all too tempting to run joyfully to the beach or pool without a minute’s delay upon rocking up at your sun-drenched destination. But the glee of having escaped the damp squib of a British summer can distract you from the very pressing matter of your suncare. Those moments of joy at feeling warmth and [...]
Mykonos calls for it-boy who gave it all up July 4, 2008 He failed to buy the Groucho, but Benjamin Fry has no regrets, writes Timothy Barber Benjamin Fry, psychotherapist, TV self-help guru and author, has come a long way. He used to be Benji Fry, stalwart of a west London scene of ultra connected upstarts such as Tom Parker Bowles and Ben Elliot, who in the [...]
Relief at CAT Abbott deal October 27, 2005 Cambridge Antibody Technology (CAT) has reached an agreement with American pharmaceutical firm Abbott about how much it should get in royalties from the sale of the blockbuster arthritis drug Humira. The deal, which sent shares in the loss-making British biopharmaceutical company up almost 4 per cent, has headed off a Court of Appeal’s case scheduled [...]
The new drug habits October 21, 2005 Pharmaceutical companies are increasingly turning to biotechnology ventures to help them rescue their flagging profits. Investors are looking at biotechnology companies to reinvigorate a moribund drug industry in a way the big pharmaceutical giants have failed to do over the last two years. Observers say companies such as America’s Pfizer or Britain’s GlaxoSmithKline, known as [...]